| ||||||||||||||||||||||||||
|
Yikes! No one wants the flu, but now that you might have it, what do you do? First, look for the symptoms: These symptoms would indicate the flu vs a common cold or virus. Contact your medical professional as soon as possible and get their advice on how you should be treated. Common sense treatments that can help with symptoms include: As you begin to feel better, be sure to address any secondary infections that may occur. These could include bronchitis or pneumonia. Any productive cough should be treated at once in the lung patient. Consult your health professional. Slowly begin to get back in to your exercise routine. Do not expect to return to a full routine immediately, but take it slowly as you regain your strength. Be sure to keep up a high intake of fluids and nutritional foods as you recover. Your need for rest will continue for 2-3 weeks and may take longer if you develop any additional infection as a result of the flu. For additional information on the flu in your state, simply go to: At this site you can also find additional information for determining if you have the flu, what to do if you contract it, more info on staph infections as a result of the flu and about anti-viral medications. Remember to wash your hands frequently, avoid crowds and inform your friends before they visit that you are at high risk. You will enjoy their company much more if you are not worried about catching a cold or bug from them. FDA MedWatch: Tamiflu [oseltamivir] not indicated in infants lessthan 1 year of age - new safety information. Date: Friday, January 02, 2004 3:58 PM MedWatch - The FDA Safety Information and Adverse Event Reporting Program Roche Laboratories and FDA notified healthcare professionals of new preclinical safety data that have implications for use of Tamiflu in very young children. Preclinical findings in juvenile rats have raised concerns regarding the use of Tamiflu in infants less than 1 year of age. A single dose of 1000 mg/kg oseltamivir phosphate (about 250 times the recommended dose in children) in 7-day-old rats resulted in deaths associated with levels of oseltamivir phosphate in the brain approximately 1500 times those seen in adult animals. It is likely that these high exposures are related to an immature blood-brain barrier. The clinical significance of these preclinical data to human infants is uncertain. Given the uncertainty in predicting the exposures in infants with immature blood-brain barriers, it is recommended that Tamiflu not be administered to children younger than 1 year. Read the 2003 MedWatch safety summary, including links to the "Dear Healthcare Professional" letter and prescribing information, at: http://www.fda.gov/medwatch/SAFETY/2003/safety03.htm#tamiflu Thank you for using MedWatch as a trusted source for timely safety information on drugs and other medical products regulated by the U.S. Food and Drug Administration. simply fill out the inquiry form Need Help Now ! (Click Here) Telephone: 540-948-6777 or 1-866-FOR-A1AA (1-866-367-2122) Fax # 540-948-6763 Copyright © 2006 Alpha-1 Advocacy Alliance, All Rights Reserved Home | Disclaimer | Privacy Policy | |||||||||||||||||||||||||